Viatris - Company Profile
Save hours of research with our analyst-prepared profile on Viatris. Get financials, SWOT, and competitor insights in one place—your competitors might already have it.
Viatris Competitors
| Competitor | Headquarters | No. of Employees | Revenue | Entity Type |
|---|---|---|---|---|
Pfizer | United States of America | 79,000 | $51.75B | Public |
AbbVie | United States of America | 47,000 | $56.2B | Public |
Johnson & Johnson | United States of America | 132,200 | $94.9B | Public |
Novartis | Switzerland | 110,000 | $48.3B | Public |
Merck & Co. | United States of America | 74,000 | $48.2B | Public |
AstraZeneca | United Kingdom | 76,600 | $44.4B | Public |
Roche | Switzerland | 97,700 | $68B | Public |
GSK (GlaxoSmithKline) | United Kingdom | 99,000 | $46.8B | Public |
Sanofi | France | 100,000 | $43.9B | Public |
Bristol-Myers Squibb | United States of America | 30,000 | $46.1B | Public |
Amgen | United States of America | 23,000 | $26B | Public |
Eli Lilly | United States of America | 35,000 | $28.5B | Public |
Teva Pharmaceutical Industries | Israel | 38,000 | $18.7B | Public |
Sun Pharmaceutical Industries | India | 31,000 | $4.9B | Public |
Takeda Pharmaceutical Company | Japan | 50,000 | $30.8B | Public |
Request the full company profile on Viatris and save hours of research with ready-to-use insights.
Overview of Viatris's competitor analysis
Viatris operates in a highly competitive pharmaceutical industry with several major players. The leading competitors include Pfizer, AbbVie, and Johnson & Johnson, each commanding significant market share and extensive research capabilities. Companies like Novartis and Merck & Co. bring strong innovation pipelines to the market. As the sector continues to evolve, traditional pharmaceutical giants such as GSK and Sanofi maintain robust portfolios across numerous therapeutic areas. This competitive landscape pushes Viatris to continuously innovate and seek strategic partnerships, emphasizing the importance of adaptability and resource efficiency in a diverse marketplace.
What are Viatris's key strengths compared to competitors?
FAQs
Pfizer
AbbVie
Johnson & Johnson
Novartis
Merck & Co.
AstraZeneca
Roche
GSK (GlaxoSmithKline)
Sanofi
Bristol-Myers Squibb
Amgen
Eli Lilly
Teva Pharmaceutical Industries
Sun Pharmaceutical Industries
Takeda Pharmaceutical Company
Overview of Viatris competitor analysis
Viatris operates in a highly competitive pharmaceutical industry with several major players. The leading competitors include Pfizer, AbbVie, and Johnson & Johnson, each commanding significant market share and extensive research capabilities. Companies like Novartis and Merck & Co. bring strong innovation pipelines to the market. As the sector continues to evolve, traditional pharmaceutical giants such as GSK and Sanofi maintain robust portfolios across numerous therapeutic areas. This competitive landscape pushes Viatris to continuously innovate and seek strategic partnerships, emphasizing the importance of adaptability and resource efficiency in a diverse marketplace.
Benchmark Viatris Against Its Competitors
- ✔ Evaluate competitor strategies, positioning, and financial strength.
- ✔ Discover how Viatris compares with market leaders.
- ✔ Identify market gaps and untapped opportunities.
- ✔ Use competitor intelligence to refine your own strategy.